Insider Trading & Ownership - Korenberg Matthew E

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Korenberg Matthew E
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2019-09-03
Purchase		2019-09-03
7:34 pm		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		500$86.18$43,09117,151
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-02-27
Option Award		2024-02-29
6:50 pm		N/A
2034-02-27		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
PRESIDENT & CHIEF OPERATING		72,960$0162,405
(Direct)		View
2024-02-15
Tax Withholding		2024-02-16
8:10 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
PRESIDENT & CHIEF OPERATING		4,778$74.6589,445
(Direct)		View
2024-01-02
Tax Withholding		2024-01-04
4:07 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
PRESIDENT & CHIEF OPERATING		2,917$72.3194,223
(Direct)		View
2023-12-05
Tax Withholding		2023-12-06
3:27 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
PRESIDENT & CHIEF OPERATING		1,984$59.6197,140
(Direct)		View
2023-06-30
Other		2023-07-10
6:42 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
PRESIDENT & CHIEF OPERATING		376$56.7899,500
(Direct)		View
2023-02-23
Option Award		2023-02-27
8:52 pm		N/A
2033-02-23		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		33,697$0123,376
(Direct)		View
2023-02-15
Tax Withholding		2023-02-17
7:23 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		2,890$72.9889,679
(Direct)		View
2022-12-28
Tax Withholding		2022-12-30
5:00 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		3,859$66.2992,569
(Direct)		View
2022-12-22
Option Award		2022-12-27
6:34 pm		N/A
2032-12-22		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		25,967$025,967
(Direct)		View
2022-12-13
Option Award		2022-12-15
6:17 pm		N/A
2032-12-13		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		44,000$0126,428
(Direct)		View
2022-11-30
Tax Withholding		2022-12-01
9:42 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		3,593$72.982,428
(Direct)		View
2022-11-01
Option Award		2022-11-03
9:10 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
President & COO		27,714$086,021
(Direct)		View
2022-07-11
Option Award		2022-08-04
4:16 pm		N/A
2032-07-11		Qualigen Therapeutics Inc.QLGNKorenberg Matthew E
Director		40,000$040,000
(Direct)		View
2022-06-30
Other		2022-07-06
8:00 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		164$75.8452,696
(Direct)		View
2022-06-10
Option Award		2022-06-14
5:54 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		8,062$052,368
(Direct)		View
2022-05-05
Option Award		2022-05-09
8:10 pm		N/A
2032-05-05		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		30,189$030,189
(Direct)		View
2022-02-15
Tax Withholding		2022-02-16
8:23 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		3,407$123.6844,306
(Direct)		View
2022-01-26
Option Award		2022-01-28
8:43 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		11,651$047,713
(Direct)		View
2022-01-26
Tax Withholding		2022-01-28
8:43 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		3,628$113.6847,713
(Direct)		View
2021-06-30
Other		2021-07-02
5:13 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		247$85.9139,937
(Direct)		View
2021-02-15
Tax Withholding		2021-02-18
6:27 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		2,309$172.4639,443
(Direct)		View
2021-02-03
Option Award		2021-02-05
5:02 pm		N/A
2031-02-03		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		22,410$053,343
(Direct)		View
2021-01-25
Option Award		2021-01-27
7:03 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		7,108$030,933
(Direct)		View
2021-01-25
Tax Withholding		2021-01-27
7:03 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		2,111$156.0130,933
(Direct)		View
2020-06-30
Other		2020-07-01
8:05 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		238$89.0326,174
(Direct)		View
2020-06-06
Option Award		2020-06-08
9:22 pm		N/A
2030-06-06		Qualigen Therapeutics Inc.QLGNKorenberg Matthew E
Director		50,000$050,000
(Direct)		View
2020-02-13
Option Award		2020-02-18
5:05 pm		N/A
2030-02-13		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		37,598$057,614
(Direct)		View
2019-12-20
Tax Withholding		2019-12-26
2:01 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		2,114$105.8720,016
(Direct)		View
2019-12-20
Option Award		2019-12-26
2:01 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		4,979$020,016
(Direct)		View
2019-06-28
Other		2019-07-02
9:49 pm		N/A
N/A		LIGAND PHARMACEUTICALS INCLGNDKorenberg Matthew E
EVP,Finance & Strategy and CFO		182$97.0316,833
(Direct)		View